AN ACT relating to coverage for prescription drugs.

Create a new section of Subtitle 17A of KRS Chapter 304 to require health plans to include a generic drug or biosimilar on the plan's formulary under specified circumstances; define terms; establish cost-sharing requirements when a generic drug or biosimilar is required to be placed on the health plan's formulary; prohibit a health plan from imposing any prior authorization, step therapy, or other limitation on coverage for a generic drug or biosimilar required to be…

Introduced: February 19, 2026

Last action: February 19, 2026

To Committee On Committees (S)

Read the full text Kentucky Legislature LegiScan

AI-generated — always verify with primary sources

Plain-language summary

Beta

This bill would require health insurance plans in Kentucky to include generic drugs and biosimilars on their approved drug lists under certain conditions, and would ban plans from making those drugs harder to access than their brand-name equivalents. It also removes the ability of insurers to require extra steps like prior authorization or step therapy before covering these lower-cost drug options. The rules would apply to most health plans, including the state employee health plan…

Open official bill text (PDF)·Report a problem with the summary